Asklepios Group: Stable business performance in Q1 2025

Asklepios Group: Stable business performance in Q1 2025

Hamburg, 14 May 2025. Asklepios Kliniken GmbH & Co. KGaA records stable business performance in Q1 2025.

From January to March 2025, the Asklepios Group’s healthcare facilities treated a total of 954,522 patients, 3.8% more than in the same period of the previous year ( 3M 2024: 919,532). Compared with the same period of the previous year, the number of inpatients treated increased to 196,129 ( 3M 2024: 196,297). In the area of outpatient care, an increase to 757,393 was recorded ( 3M 2024: 723,235).

Revenues of the Asklepios Group saw a 10.2% increase to reach EUR 1.56 billion in the first quarter of 2025 (2024: EUR 1.41 billion. Consolidated net income (EAT) for January to March 2025 totalled EUR 22.5 million ( 3M 2024: EUR 18.5 million). The EAT margin was 1.4% ( 3M 2024: 1.3%). Investments in the first quarter of 2025 totalled EUR 69.5 million ( 3M 2024: EUR 67.4 million).

As at 31 March 2025, the Asklepios Group enjoys a stable financial position. The equity capital ratio was 30.4% as at 31 March 2025 (31 December 2024: 30.5%). The net debt ratio stood at 2.8x (31 December 2024: 2.9x).

About Asklepios

Asklepios Kliniken is one of the leading operators of private hospitals and healthcare facilities in Germany. The hospital group has an established track record for delivering high-quality medical care to its patients with a clear commitment to medical quality, innovation and social responsibility. Currently, the Asklepios Group has some 160 healthcare facilities throughout Germany. These include acute hospitals of all care levels, university hospitals, specialised clinics, psychiatric and forensic facilities, rehabilitation hospitals, nursing homes and medical care centres. During financial year 2024, over 3.6 million patients were treated at Asklepios’ healthcare facilities. The Group employs more than 70,000 persons.

The Quarterly Statement as at 31 March 2025 can be accessed at Asklepios - Publikationen.

IR contact:
Mirjam Constantin
Head of Corporate & ESG Reporting/ Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 - 61462 Königstein-Falkenstein
Tel: +49 61 74 90-1166
ir@asklepios.com

PR contact:
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 - 22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639 
presse@asklepios.com

Visit Asklepios on the Internet, Meta or YouTube:
www.asklepios.com
gesundleben.asklepios.com
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken
Nursing blog: “Wir sind Pflege”

Sign up for the Asklepios Newsletter:
https://www.asklepios.com/konzern/newsletter-anmeldung/